Oluwaseyi A. Olawale is a biotechnology entrepreneur, bioinformatician, researcher, and innovation leader, and the Founder and Chief Executive Officer of Genomac Holdings, a multidisciplinary innovation and development organization committed to building a sustainable future in biotechnology, healthcare, and technology.
With a background in microbiology, biotechnology, bioinformatics, and computational life sciences, Oluwaseyi works at the intersection of genomics, artificial intelligence, healthcare innovation, scientific research, and digital technology. His work focuses on making advanced research tools more accessible, strengthening scientific capacity in Africa, and translating research into practical real-world solutions.
Through Genomac Holdings, he leads initiatives that bridge the gap between cutting-edge genomics research and public understanding, with a particular emphasis on developing science communication frameworks suited to the digital age. Oluwaseyi is committed to building scientific ecosystems that are inclusive, accessible, and capable of driving meaningful change in communities that have historically been underserved by advances in biotechnology and health innovation.
He believes that the future of genomics depends not only on scientific discovery, but on the capacity of scientists, communicators, and technologists to work together in making complex knowledge meaningful to the public, policymakers, and the next generation of innovators.
